BackCheckpoint Therapeutics Overview

Checkpoint Therapeutics Long Term Debt

Latest long-term debt for CKPT: $0.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer average

Loading

Checkpoint Therapeutics Long Term Debt History

Loading

Checkpoint Therapeutics vs. peers: Long Term Debt Comparison

Loading

Checkpoint Therapeutics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Checkpoint Therapeutics (CKPT) FAQ

Checkpoint Therapeutics (CKPT) currently reports a long-term debt of $0 as of March 2025. In the prior-year period, the figure was $0. Use the charts on this page to explore Checkpoint Therapeutics's long-term debt history and peer comparisons.

Checkpoint Therapeutics's long-term debt changed from $0 to $0 (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Checkpoint Therapeutics reported $0 in long-term debt as of March 2025. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Checkpoint Therapeutics, and consider following CKPT for alerts when major investors trade the stock.

Checkpoint Therapeutics is classified in the Healthcare sector. On long-term debt, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CKPT with unrelated industries.